Natural Alternatives International (NAII) 10-Q 11 Feb 20 2020 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Dec. 31, 2019	Feb. 11, 2020
Document Information [Line Items]
Entity Registrant Name	NATURAL ALTERNATIVES INTERNATIONAL INC
Entity Central Index Key	0000787253
Trading Symbol	naii
Current Fiscal Year End Date	--06-30
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Common Stock, Shares Outstanding (in shares)		6,875,166
Entity Shell Company	false
Document Type	10-Q
Document Period End Date	Dec. 31, 2019
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q2
Amendment Flag	false
Title of 12(b) Security	Common Stock, $0.01 par value per share
Entity Interactive Data Current	Yes

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Dec. 31, 2019	Jun. 30, 2019
Current assets:
Cash and cash equivalents	$ 26,900	$ 25,040
Accounts receivable - less allowance for doubtful accounts of $0 at December 31, 2019 and $25 at June 30, 2019	14,227	15,964
Inventories, net	22,650	26,003
Income tax receivable	1,180	901
Forward contracts	1,636	1,978
Prepaids and other current assets	1,929	1,500
Total current assets	68,522	71,386
Property and equipment, net	20,613	21,085
Operating lease right-of-use assets	19,523
Other noncurrent assets, net	863	1,019
Total assets	109,521	93,490
Current liabilities:
Accounts payable	5,437	8,634
Accrued liabilities	3,292	2,782
Accrued compensation and employee benefits	882	1,615
Income taxes payable	1,591	1,219
Total current liabilities	11,202	14,250
Long-term liability – Operating leases	19,742
Long-term pension liability	255	246
Deferred rent		543
Income taxes payable, noncurrent	1,349	1,349
Deferred income taxes	(853)	(1,018)
Total liabilities	33,401	17,406
Commitments and contingencies (Note L)
Stockholders’ equity:
Preferred stock; $.01 par value; 500,000 shares authorized; none issued or outstanding	0	0
Common stock; $.01 par value; 20,000,000 shares authorized; issued and outstanding (net of treasury shares) 7,055,404 at December 31, 2019 and 7,225,072 at June 30, 2019	87	87
Additional paid-in capital	27,172	26,280
Retained earnings	58,500	57,380
Treasury stock, at cost, 1,801,273 shares at December 31, 2019 and 1,626,605 June 30, 2019	(9,287)	(7,955)
Accumulated other comprehensive (loss) gain	(352)	292
Total stockholders’ equity	76,120	76,084
Total liabilities and stockholders’ equity	$ 109,521	$ 93,490

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) $ in Thousands	Dec. 31, 2019	Jun. 30, 2019
Accounts receivable, allowance for doubtful accounts	$ 0	$ 25
Preferred stock par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	500,000	500,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	20,000,000	20,000,000
Common stock, shares outstanding (in shares)	7,055,404	7,225,072
Treasury stock, shares (in shares)	1,801,273	1,626,605

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income and Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Net sales	$ 29,103	$ 36,043	$ 58,298	$ 72,575
Cost of goods sold	24,042	29,607	48,853	58,976
Gross profit	5,061	6,436	9,445	13,599
Selling, general and administrative	4,363	4,229	8,802	8,668
Income from operations	698	2,207	643	4,931
Other (expense) income:
Interest income	50	529	129	1,084
Interest expense	(7)	(9)	(11)	(12)
Foreign exchange (loss) gain	(162)	37	(53)	(41)
Other, net	(5)	(14)	(12)	9
Total other (expense) income	(124)	543	53	1,040
Income before income taxes	574	2,750	696	5,971
Provision for income taxes	98	569	124	1,231
Net income	476	2,181	572	4,740
Unrealized (loss) gain resulting from change in fair value of derivative instruments, net of tax	(903)	852	(516)	1,235
Comprehensive (loss) income	$ (427)	$ 3,033	$ 56	$ 5,975
Net income per common share:
Basic (in dollars per share)	$ 0.07	$ 0.32	$ 0.08	$ 0.70
Diluted (in dollars per share)	$ 0.07	$ 0.31	$ 0.08	$ 0.68
Weighted average common shares outstanding
Basic (in shares)	6,795,269	6,807,979	6,818,249	6,786,470
Diluted (in shares)	6,885,934	6,999,223	6,935,580	6,982,083

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	AOCI Attributable to Parent [Member]	Total
Balance (in shares) at Jun. 30, 2018	8,656,677			1,098,268
Balance at Jun. 30, 2018	$ 85	$ 24,486	$ 50,839	$ (6,584)	$ (578)	$ 68,248
Issuance of common stock for restricted stock grants (in shares)	15,000
Issuance of common stock for restricted stock grants
Compensation expense related to stock compensation plans		1,299				1,299
Repurchase of common stock (in shares)				44,487
Repurchase of common stock				$ (430)		(430)
Unrealized gain (loss) resulting from change in fair value of derivative instruments, net of tax					1,235	1,235
Net income			4,740			4,740
Forfeiture of restricted stock (in shares)				5,000
Forfeiture of restricted stock
Issuance of common stock for stock option exercise (in shares)	5,000					5,000
Issuance of common stock for stock option exercise		38				$ 38
Balance (in shares) at Dec. 31, 2018	8,676,677			1,147,755
Balance at Dec. 31, 2018	$ 85	25,823	55,579	$ (7,014)	657	75,130
Balance (in shares) at Sep. 30, 2018	8,676,677			1,098,942
Balance at Sep. 30, 2018	$ 85	25,177	53,398	$ (6,590)	(195)	71,876
Compensation expense related to stock compensation plans		646				646
Repurchase of common stock (in shares)				43,813
Repurchase of common stock				$ (424)		(424)
Unrealized gain (loss) resulting from change in fair value of derivative instruments, net of tax					852	852
Net income			2,180			2,181
Forfeiture of restricted stock (in shares)				5,000
Forfeiture of restricted stock
Issuance of common stock for stock option exercise (in shares)						0
Balance (in shares) at Dec. 31, 2018	8,676,677			1,147,755
Balance at Dec. 31, 2018	$ 85	25,823	55,579	$ (7,014)	657	$ 75,130
Balance (in shares) at Jun. 30, 2019	8,851,677			1,626,605
Balance at Jun. 30, 2019	$ 87	26,280	57,380	$ (7,955)	292	76,084
Issuance of common stock for restricted stock grants (in shares)	5,000
Issuance of common stock for restricted stock grants
Compensation expense related to stock compensation plans		892				892
Repurchase of common stock (in shares)				159,668
Repurchase of common stock				$ (1,332)		(1,332)
Unrealized gain (loss) resulting from change in fair value of derivative instruments, net of tax					(516)	(516)
Net income			572			572
Forfeiture of restricted stock (in shares)				15,000
Forfeiture of restricted stock
Cumulative-effect adjustment pursuant to adoption of ASU 2016-02 (Note E) | Accounting Standards Update 2016-02 [Member]			420			420
Tax Cuts and Jobs Act, Reclassification from AOCI to Retained Earnings, Tax Effect | Accounting Standards Update 2018-02 [Member]			128		(128)
Tax Cuts and Jobs Act, Reclassification from AOCI to Retained Earnings, Tax Effect					(128)
Issuance of common stock for stock option exercise (in shares)						0
Balance (in shares) at Dec. 31, 2019	8,856,677			1,801,273
Balance at Dec. 31, 2019	$ 87	27,172	58,500	$ (9,287)	(352)	$ 76,120
Balance (in shares) at Sep. 30, 2019	8,851,677			1,643,322
Balance at Sep. 30, 2019	$ 87	26,713	58,024	$ (7,970)	551	77,405
Issuance of common stock for restricted stock grants (in shares)	5,000
Issuance of common stock for restricted stock grants
Compensation expense related to stock compensation plans		459				459
Repurchase of common stock (in shares)				157,951
Repurchase of common stock				$ (1,317)		(1,317)
Unrealized gain (loss) resulting from change in fair value of derivative instruments, net of tax					(903)	(903)
Net income			476			$ 476
Tax Cuts and Jobs Act, Reclassification from AOCI to Retained Earnings, Tax Effect
Issuance of common stock for stock option exercise (in shares)						0
Balance (in shares) at Dec. 31, 2019	8,856,677			1,801,273
Balance at Dec. 31, 2019	$ 87	$ 27,172	$ 58,500	$ (9,287)	$ (352)	$ 76,120

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash flows from operating activities
Net income	$ 572	$ 4,740
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,966	1,597
Non-cash sales discount		490
Non-cash compensation	892	809
Pension expense, net of contributions	9	25
Loss (gain) on disposal of assets	122	(1)
Changes in operating assets and liabilities:
Accounts receivable, net	1,737	1,086
Inventories, net	3,353	92
Operating lease right-of-use assets and liabilities, net	96
Prepaids and other assets	(612)	(1,094)
Accounts payable and accrued liabilities	(2,687)	(546)
Accrued compensation and employee benefits	(733)	380
Income taxes	93	609
Net cash provided by operating activities	4,808	8,187
Cash flows from investing activities
Purchases of property and equipment	(1,633)	(2,662)
Proceeds from sale of property and equipment	17	19
Proceeds from collection of notes receivable		1,500
Net cash used in investing activities	(1,616)	(1,143)
Cash flows from financing activities
Repurchase of common stock	(1,332)	(430)
Issuance of common stock		38
Net cash used in financing activities	(1,332)	(392)
Net increase in cash and cash equivalents	1,860	6,652
Cash and cash equivalents at beginning of period	25,040	23,613
Cash and cash equivalents at end of period	26,900	30,265
Supplemental disclosures of cash flow information
Interest	11	7
Taxes	18	733
Disclosure of non-cash activities:
Unrealized (loss) gain resulting from change in fair value of derivative instruments, net of tax	$ (516)	$ 1,235

Note A - Basis of Presentation

Note A - Basis of Presentation and Summary of Significant Accounting Policies	6 Months Ended
	Dec. 31, 2019
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]	A. Basis of Presentation and Summary of Significant Accounting Policies The accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10 six December 31, 2019 not You should read the financial statements and these notes, which are an integral part of the financial statements, together with our audited financial statements included in our Annual Report on Form 10 June 30, 2019 ( “2019 2019 Recently Issued Accounting Pronouncements Other recently issued accounting pronouncements not not not Net Income per Common Share We compute net income per common share using the weighted average number of common shares outstanding during the period, and diluted net income per common share using the additional dilutive effect of all dilutive securities. The dilutive impact of stock options and unvested restricted stock accounts for the additional weighted average shares of common stock outstanding for our diluted net income per common share computation. We calculated basic and diluted net income per common share as follows (in thousands, except per share data): Three Months Ended Six Months Ended December 31, December 31, 2019 2018 2019 2018 Numerator Net income $ 476 $ 2,181 $ 572 $ 4,740 Denominator Basic weighted average common shares outstanding 6,795 6,808 6,818 6,786 Dilutive effect of stock options and restricted stock 91 191 117 196 Diluted weighted average common shares outstanding 6,886 6,999 6,935 6,982 Basic net income per common share $ 0.07 $ 0.32 $ 0.08 $ 0.70 Diluted net income per common share $ 0.07 $ 0.31 $ 0.08 $ 0.68 We did not three six December 31, 2019 December 31, 2018 Revenue Recognition We record revenue based on a five 1 2 3 4 5 Revenue is measured as the net amount of consideration expected to be received in exchange for fulfilling one 30 Revenue is recognized at the point in time that each of our performance obligation is fulfilled, and control of the ordered products is transferred to the customer. This transfer occurs when the product is shipped, or in some cases, when the product is delivered to the customer. We provide early payment discounts to certain customers. Based on historical payment trends, we expect that these customers will take advantage of these early payment discounts. The cost of these discounts is reported as a reduction to the transaction price. If the actual discounts differ from those estimated, the difference is also reported as a change in the transaction price. Except for product defects, no December 31, 2019, no On August 7, 2017, three 24 500,000 5 may On March 31, 2019, August 6, 2025. 400,000 one fourth 2019 $395,000 three December 31, 2019 $790,000 six December 31, 2019. $245,000 three December 31, 2018 $490,000 six December 31, 2018. We currently own certain U.S. patents, and each patent’s corresponding foreign patent applications. All of these patents and patent rights relate to the ingredient known as “beta-alanine”, which is marketed and sold under our CarnoSyn® and SR CarnoSyn® trade names. We recorded beta-alanine raw material sales and royalty and licensing income as a component of revenue in the amount of $4.3 three December 31, 2019 $7.5 six December 31, 2019. $4.4 three December 31, 2018 $9.8 six December 31, 2018. $192,000 three December 31, 2019 $359,000 six December 31, 2019. $178,000 three December 31, 2018 $441,000 six December 31, 2018. Notes Receivable On September 30, 2017, 12 one $1.5 September 30, 2018, September 30, 2018 December 28, 2018 $25,000. fifteen 15% not three six December 31, 2019. three December 31, 2018 $46,000 six December 31, 2018 $104,000 Stock-Based Compensation We had an omnibus equity incentive plan that was approved by our Board of Directors effective October 15, 2009 November 30, 2009 "2009 2009 October 15, 2019. October 15, 2019 ( “2019 December 6, 2019. 2019 may We did not three six December 31, 2019 December 31, 2018. No three six December 31, 2019. No three December 31, 2018. six December 31, 2018, 5,000 no three six December 31, 2019 December 31, 2018. During the three six December 31, 2019, 5,000 six December 31, 2018, 15,000 not three December 31, 2018. three December 31, 2019, no six December 31, 2019, 15,000 three six December 31, 2018, 5,000 $459,000 three December 31, 2019, $892,000 six December 31, 2019. $400,000 three December 31, 2018 $809,000 six December 31, 2018. Fair Value of Financial Instruments Except for cash and cash equivalents and assets and liabilities related to our pension plan, as of December 31, 2019, June 30, 2019, not 1. 2 December 31, 2019 $1.6 June 30, 2019 $2.3 third December 31, 2019, June 30, 2019, not 3. not 2019 three six December 31, 2019.

Note B - Inventories, Net

Note B - Inventories, Net	6 Months Ended
	Dec. 31, 2019
Notes to Financial Statements
Inventory Disclosure [Text Block]	B. Inventories, net Inventories, net consisted of the following (in thousands): Dec ember 3 1 , 201 9 June 30, 201 9 Raw materials $ 14,228 $ 18,322 Work in progress 2,696 3,785 Finished goods 6,255 5,002 Reserve (529 ) (1,106 ) $ 22,650 $ 26,003 The inventory reserve as of December 31, 2019 June 30, 2019, $39,000 $686,000, first

Note C - Property and Equipment

Note C - Property and Equipment	6 Months Ended
	Dec. 31, 2019
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	C. Property and Equipment Property and equipment consisted of the following (in thousands): Depreciable Life In Years Dec ember 3 1 , 2019 June 30, 201 9 Land NA $ 1,200 $ 1,200 Building and building improvements 7 – 39 3,743 3,729 Machinery and equipment 3 – 12 31,130 30,216 Office equipment and furniture 3 – 5 5,284 5,190 Vehicles 3 255 314 Leasehold improvements 1 – 15 17,509 17,468 Total property and equipment 59,121 58,117 Less: accumulated depreciation and amortization (38,508 ) (37,032 ) Property and equipment, net $ 20,613 $ 21,085

Note D - Other Comprehensive (L

Note D - Other Comprehensive (Loss) Income	6 Months Ended
	Dec. 31, 2019
Notes to Financial Statements
Comprehensive Income (Loss) Note [Text Block]	D. Other Comprehensive ( Loss ) Income Other comprehensive (loss) income (“OCL” and “OCI”) consisted of the following during the three six December 31, 2019 December 31, 2018 ( Three Months Ended Six Months Ended December 31, 2019 December 31, 201 9 Unrealized Unrealized Defined Gains Defined Gains Benefit (Losses) on Benefit (Losses) on Pension Cash Flow Pension Cash Flow Plan Hedges Total Plan Hedges Total Beginning Balance $ (565 ) $ 1,116 $ 551 $ (491 ) $ 783 $ 292 ASU 2018-02 Adjustment - - - (74 ) (54 ) (128 ) OCI/OCL before reclassifications - (369 ) (369 ) - 932 932 Amounts reclassified from OCI - (808 ) (808 ) - (1,612 ) (1,612 ) Tax effect of OCI activity - 274 274 - 164 164 Net current period OCI/OCL - (903 ) (903 ) (74 ) (570 ) (644 ) Ending Balance $ (565 ) $ 213 $ (352 ) $ (565 ) $ 213 $ (352 ) Three Months Ended Six Months Ended December 31, 2018 December 31, 2018 Unrealized Unrealized Defined Gains Defined Gains Benefit (Losses) on Benefit (Losses) on Pension Cash Flow Pension Cash Flow Plan Hedges Total Plan Hedges Total Beginning Balance $ (387 ) $ 192 $ (195 ) $ (387 ) $ (191 ) $ (578 ) OCI/OCL before reclassifications - 1,784 1,784 - 2,729 2,729 Amounts reclassified from OCI - (674 ) (674 ) - (1,120 ) (1,120 ) Tax effect of OCI activity - (258 ) (258 ) - (374 ) (374 ) Net current period OCI/OCL - 852 852 - 1,235 1,235 Ending Balance $ (387 ) $ 1,044 $ 657 $ (387 ) $ 1,044 $ 657 On July 1, 2019, 2018 02, Income Statement-Reporting Comprehensive Income (Topic 220 2018 2017 $128,000

Note E - Leases

Note E - Leases	6 Months Ended
	Dec. 31, 2019
Notes to Financial Statements
Lessee, Operating Leases [Text Block]	E. Leases On July 1, 2019, 842, Leases 842, 842, July 1, 2019, July 1, 2019 not 840, Leases 840, not not 842, 842 840. no We adopted ASC 842 July 1, 2019. 842 July 1, 2019, no 840 842, $20.7 $20.9 840, July 1, 2019, 842, not 1 2 3 not The impact of the adoption of ASC 842 June 30, 2019 As Reported June 30, 2019 Adoption of ASC 842 Increase (Decrease) Balance of July 1, 2019 Operating lease right-of-use assets $ — $ 20,774 $ 20,774 Total assets 93,490 20,774 114,264 Deferred rent 543 (543 ) — Long-term liability – Operating leases — 20,897 20,897 Retained earnings 57,380 420 57,800 Total liabilities and equity 93,490 20,774 114,264 We lease substantially all of our product manufacturing and support office space used to conduct our business. We adopted ASC 842 July, 1 2019. 1 2 3 Leases are classified as either finance leases or operating leases. A lease must be classified as a finance lease if any of the following criteria are met: the lease transfers ownership of the asset by the end of the lease term, the lease contains an option to purchase the asset that is reasonably certain to be exercised, the lease term is for a major part of the remaining useful life of the asset or the present value of the lease payments equals or exceeds substantially all of the fair value of the asset. A lease is classified as an operating lease if it does not For all leases at the lease commencement date, a right-of-use asset and a lease liability are recognized. The right-of-use asset represents the right to use the leased asset for the lease term. The lease liability represents the present value of the lease payments under the lease. The right-of-use asset is initially measured at cost, which primarily comprises the initial amount of the lease liability, plus any initial direct costs incurred, consisting mainly of brokerage commissions, less any lease incentives received. All right-of-use assets are reviewed for impairment. The lease liability is initially measured at the present value of the lease payments, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, our secured incremental borrowing rate for the same term as the underlying lease. For our real estate and other operating leases, we use our secured incremental borrowing rate. For our finance leases, we will use the rate implicit in the lease or our secured incremental borrowing rate if the implicit lease rate cannot be determined. Lease payments included in the measurement of the lease liability comprise the following: the fixed noncancelable lease payments, payments for optional renewal periods where it is reasonably certain the renewal period will be exercised, and payments for early termination options unless it is reasonably certain the lease will not Some of our manufacturing leases contain variable lease payments, including payments based on an index or rate. Variable lease payments based on an index or rate are initially measured using the index or rate in effect at lease commencement and separated into lease and non-lease components based on the initial amount stated in the lease or standalone selling prices. Lease components are included in the measurement of the initial lease liability. Additional payments based on the change in an index or rate, or payments based on a change in our portion of the operating expenses, including real estate taxes and insurance, are recorded as a period expense when incurred. Lease modifications result in remeasurement of the lease liability. Lease expense for operating leases consists of the lease payments plus any initial direct costs, primarily brokerage commissions, and is recognized on a straight-line basis over the lease term. Included in lease expense are any variable lease payments incurred in the period that were not We have elected not 12 not

Note F - Debt

Note F - Debt	6 Months Ended
	Dec. 31, 2019
Notes to Financial Statements
Debt Disclosure [Text Block]	F . Debt On July 1, 2019, February 1, 2021, November 1, 2022. $10.0 may no Under the terms of the Credit Agreement, borrowings are subject to eligibility requirements including maintaining (i) a ratio of total liabilities to tangible net worth of not 1.25 1.0 not 1.75 1.0 $100,000 1.25% one 1.25% first may may $100,000, December 31, 2019, Our obligations under the Credit Agreement are secured by our accounts receivable and other rights to payment, general intangibles, inventory, equipment and fixtures. We also have credit approval with Wells Fargo Bank, N.A. which allows us to hedge foreign currency exposures up to 30 24 We did not three December 31, 2019. December 31, 2019, $10.0

Note G - Economic Dependency

Note G - Economic Dependency	6 Months Ended
	Dec. 31, 2019
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	G . Economic Dependency We had substantial net sales to certain customers during the periods shown in the following table. The loss of any of these customers, or a significant decline in (i) sales to these customers, (ii) the growth rate of sales to these customers, or (iii) these customers’ ability to make payments when due, each individually could have a material adverse impact on our net sales and net income. Net sales to any one 10% Three Months Ended December 31, Six Months Ended December 31, 2019 2018 2019 2018 Customer 1 $ 12,422 $ 17,750 $ 26,776 $ 38,827 Customer 2 5,539 6,196 9,509 9,926 Customer 3 (a) 3,890 (a) (a) $ 17,961 $ 27,836 $ 36,285 $ 48,753 (a) Sales were less than 10% We buy certain products, including beta-alanine, from a limited number of raw material suppliers who meet our quality standards. The loss of any of these suppliers could have a material adverse impact on our net sales and net income. Raw material purchases from any one 10% Three Months Ended December 31, Six Months Ended December 31, 2019 2018 2019 2018 Supplier 1 $ 1,734 (a) $ 3,227 4,472 Supplier 2 (a) 1,866 (a) (a) $ 1,734 1,866 $ 3,227 4,472 (a) Purchases were less than 10% Financial instruments that subject us to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. We place our cash and cash equivalents with highly rated financial institutions. Credit risk with respect to receivables is concentrated with three 77.1% December 31, 2019 76.8% June 30, 2019. 16.1% December 31, 2019, 8.0% June 30, 2019.

Note H - Segment Information

Note H - Segment Information	6 Months Ended
	Dec. 31, 2019
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	H . Segment Information Our business consists of two two We evaluate performance based on a number of factors. The primary performance measures for each segment are net sales and income or loss from operations before the allocation of certain corporate level expenses. Operating income or loss for each segment does not not not 2019 Our operating results by business segment were as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2019 2018 2019 2018 Net Sales Private label contract manufacturing $ 24,831 $ 31,660 $ 50,841 $ 62,747 Patent and trademark licensing 4,272 4,383 7,457 9,828 Total Net Sales $ 29,103 $ 36,043 $ 58,298 $ 72,575 Three Months Ended December 31, Six Months Ended December 31, 2019 2018 2019 2018 Income from Operations Private label contract manufacturing $ 1,697 $ 2,853 $ 3,312 $ 5,999 Patent and trademark licensing 842 1,475 1,054 3,276 Income from operations of reportable segments 2,539 4,328 4,366 9,275 Corporate expenses not allocated to segments (1,841 ) (2,121 ) (3,723 ) (4,344 ) Total Income from Operations $ 698 $ 2,207 $ 643 $ 4,931 Dec ember 31, 2019 June 30, 201 9 Total Assets Private-label contract manufacturing $ 89,666 $ 74,431 Patent and trademark licensing 19,855 19,059 $ 109,521 $ 93,490 Our private-label contract manufacturing products are sold both in the U.S. and in markets outside the U.S., including Europe, Canada, Australia, New Zealand, and Asia. Our primary markets outside the U.S. are Europe and Asia. Our patent and trademark licensing activities are primarily based in the U.S. Net sales by geographic region, based on the customers’ location, were as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2019 2018 2019 2018 United States $ 17,591 $ 18,549 $ 35,776 $ 36,195 Markets outside of the United States 11,512 17,494 22,522 36,380 Total $ 29,103 $ 36,043 $ 58,298 $ 72,575 Products manufactured by our Swiss subsidiary ("NAIE") accounted for 91% three December 31, 2019 90% six December 31, 2019. 90% three December 31, 2018 80% six December 31, 2018. No three six December 31, 2019 2018. Long-lived assets by geographic region, based on the location of the company or subsidiary at which they were located or made, were as follows (in thousands): December 31, 2019 June 30, 2019 United States $ 22,303 $ 10,977 Europe 17,833 10,108 Total Long-Lived Assets $ 40,136 $ 21,085 As a result of the implementation of ASC 842, Total assets by geographic region, based on the location of the company or subsidiary at which they were located or made, were as follows (in thousands): Dec ember 3 1 , 2019 June 30, 2019 United States $ 61,620 $ 54,785 Europe 47,901 38,705 Total Assets $ 109,521 $ 93,490 Capital expenditures by geographic region, based on the location of the company or subsidiary at which they were located or made, were as follows (in thousands): Six Months Ended Dec ember 3 1 , 2019 Dec ember 3 1 , 2018 United States $ 578 $ 708 Europe 1,055 1,954 Total Capital Expenditures $ 1,633 $ 2,662

Note I - Income Taxes

Note I - Income Taxes	6 Months Ended
	Dec. 31, 2019
Notes to Financial Statements
Income Tax Disclosure [Text Block]	I . Income Taxes The effective tax rate for the three December 31, 2019 17.0% six December 31, 2019 17.8%. 2019 21% three December 31, 2018 20.7% six December 31, 2018 20.6%. To determine our quarterly provision for income taxes, we use an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions to which we are subject. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rate from quarter to quarter. We recognize interest and penalties related to uncertain tax positions, if any, as an income tax expense. There were no three six December 31, 2019 three sixth December 31, 2018. We record valuation allowances to reduce our deferred tax assets to an amount we believe is more likely than not not three six December 31, 2019, no Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are measured using enacted tax rates, for each of the jurisdictions in which we operate, expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as income or expense in the period that includes the enactment date for such new rates. We are subject to taxation in the U.S., Switzerland and various state jurisdictions. Our tax years for the fiscal year ended June 30, 2016 June 30, 2007 June 30, 2018 It is our policy to establish reserves based on management’s assessment of exposure for certain positions taken in previously filed tax returns that may no three six December 31, 2019.

Note J - Treasury Stock

Note J - Treasury Stock	6 Months Ended
	Dec. 31, 2019
Notes to Financial Statements
Treasury Stock [Text Block]	J . Treasury Stock The Board of Directors has authorized a total of $7.0 December 31, 2019. January 8, 2020, $2.0 $9.0 may, During the three December 31, 2019 150,307 $8.33 $1.3 six December 31, 2019 151,338 $8.33 $1.3 three six December 31, 2018, 36,949 $358,000 During the three December 31, 2019 7,644 $8.67 $66,000. six December 31, 2019, 8,330 $8.74 $73,000. three December 31, 2018, 6,864 $9.66 $66,000. six December 31, 2018, 7,538 $9.66 $72,000.

Note K - Derivatives and Hedgin

Note K - Derivatives and Hedging	6 Months Ended
	Dec. 31, 2019
Notes to Financial Statements
Derivative Instruments and Hedging Activities Disclosure [Text Block]	K. Derivatives and Hedging We are exposed to gains and losses resulting from fluctuations in foreign currency exchange rates relating to forecasted product sales denominated in foreign currencies and to other transactions of NAIE, our foreign subsidiary. As part of our overall strategy to manage the level of exposure to the risk of fluctuations in foreign currency exchange rates, we may no As of December 31, 2019, August 2021. For foreign currency contracts designated as cash flow hedges, hedge effectiveness is measured using the spot rate. Changes in the spot-forward differential are excluded from the test of hedge effectiveness and are recorded currently in earnings as interest income or expense. We measure effectiveness by comparing the cumulative change in the hedge contract with the cumulative change in the hedged item as well as ensuring the assumptions we made at hedge inception have not No three six December 31, 2019 December 31, 2018. We monitor the probability of forecasted transactions as part of the hedge effectiveness testing on a quarterly basis. During the three six December 31, 2019 December 31, 2018, not As of December 31, 2019, $40.5 34.2 December 31, 2019, $276,000 $305,000 12 As of December 31, 2019, $1.6 three December 31, 2019, $369,000 $808,000 six December 31, 2019, $932,000 $1.6 $54,000 June 30, 2019, $2.0 $312,000 three December 31, 2018, $1.3 $211,000 six December 31, 2018, $1.8 $169,000 On July 1, 2019, No. 2017 12, Derivatives and Hedging (Topic 815 No. 2017 12 $261,000 three December 31, 2019, $498,000 six December 31, 2019. $464,000 three December 31, 2018, $951,000 six December 31, 2018.

Note L - Contingencies

Note L - Contingencies	6 Months Ended
	Dec. 31, 2019
Notes to Financial Statements
Legal Matters and Contingencies [Text Block]	L . Contingencies From time to time, we become involved in various investigations, claims and legal proceedings that arise in the ordinary course of our business. These matters may may not not

Significant Accounting Policies

Significant Accounting Policies (Policies)	6 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued Accounting Pronouncements Other recently issued accounting pronouncements not not not
Earnings Per Share, Policy [Policy Text Block]	Net Income per Common Share We compute net income per common share using the weighted average number of common shares outstanding during the period, and diluted net income per common share using the additional dilutive effect of all dilutive securities. The dilutive impact of stock options and unvested restricted stock accounts for the additional weighted average shares of common stock outstanding for our diluted net income per common share computation. We calculated basic and diluted net income per common share as follows (in thousands, except per share data): Three Months Ended Six Months Ended December 31, December 31, 2019 2018 2019 2018 Numerator Net income $ 476 $ 2,181 $ 572 $ 4,740 Denominator Basic weighted average common shares outstanding 6,795 6,808 6,818 6,786 Dilutive effect of stock options and restricted stock 91 191 117 196 Diluted weighted average common shares outstanding 6,886 6,999 6,935 6,982 Basic net income per common share $ 0.07 $ 0.32 $ 0.08 $ 0.70 Diluted net income per common share $ 0.07 $ 0.31 $ 0.08 $ 0.68 We did not three six December 31, 2019 December 31, 2018
Revenue from Contract with Customer [Policy Text Block]	Revenue Recognition We record revenue based on a five 1 2 3 4 5 Revenue is measured as the net amount of consideration expected to be received in exchange for fulfilling one 30 Revenue is recognized at the point in time that each of our performance obligation is fulfilled, and control of the ordered products is transferred to the customer. This transfer occurs when the product is shipped, or in some cases, when the product is delivered to the customer. We provide early payment discounts to certain customers. Based on historical payment trends, we expect that these customers will take advantage of these early payment discounts. The cost of these discounts is reported as a reduction to the transaction price. If the actual discounts differ from those estimated, the difference is also reported as a change in the transaction price. Except for product defects, no December 31, 2019, no On August 7, 2017, three 24 500,000 5 may On March 31, 2019, August 6, 2025. 400,000 one fourth 2019 $395,000 three December 31, 2019 $790,000 six December 31, 2019. $245,000 three December 31, 2018 $490,000 six December 31, 2018. We currently own certain U.S. patents, and each patent’s corresponding foreign patent applications. All of these patents and patent rights relate to the ingredient known as “beta-alanine”, which is marketed and sold under our CarnoSyn® and SR CarnoSyn® trade names. We recorded beta-alanine raw material sales and royalty and licensing income as a component of revenue in the amount of $4.3 three December 31, 2019 $7.5 six December 31, 2019. $4.4 three December 31, 2018 $9.8 six December 31, 2018. $192,000 three December 31, 2019 $359,000 six December 31, 2019. $178,000 three December 31, 2018 $441,000 six December 31, 2018.
Financing Receivable [Policy Text Block]	Notes Receivable On September 30, 2017, 12 one $1.5 September 30, 2018, September 30, 2018 December 28, 2018 $25,000. fifteen 15% not three six December 31, 2019. three December 31, 2018 $46,000 six December 31, 2018 $104,000
Share-based Payment Arrangement [Policy Text Block]	Stock-Based Compensation We had an omnibus equity incentive plan that was approved by our Board of Directors effective October 15, 2009 November 30, 2009 "2009 2009 October 15, 2019. October 15, 2019 ( “2019 December 6, 2019. 2019 may We did not three six December 31, 2019 December 31, 2018. No three six December 31, 2019. No three December 31, 2018. six December 31, 2018, 5,000 no three six December 31, 2019 December 31, 2018. During the three six December 31, 2019, 5,000 six December 31, 2018, 15,000 not three December 31, 2018. three December 31, 2019, no six December 31, 2019, 15,000 three six December 31, 2018, 5,000 $459,000 three December 31, 2019, $892,000 six December 31, 2019. $400,000 three December 31, 2018 $809,000 six December 31, 2018.
Fair Value Measurement, Policy [Policy Text Block]	Fair Value of Financial Instruments Except for cash and cash equivalents and assets and liabilities related to our pension plan, as of December 31, 2019, June 30, 2019, not 1. 2 December 31, 2019 $1.6 June 30, 2019 $2.3 third December 31, 2019, June 30, 2019, not 3. not 2019 three six December 31, 2019.

Note A - Basis of Presentatio_2

Note A - Basis of Presentation and Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Dec. 31, 2019
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended Six Months Ended December 31, December 31, 2019 2018 2019 2018 Numerator Net income $ 476 $ 2,181 $ 572 $ 4,740 Denominator Basic weighted average common shares outstanding 6,795 6,808 6,818 6,786 Dilutive effect of stock options and restricted stock 91 191 117 196 Diluted weighted average common shares outstanding 6,886 6,999 6,935 6,982 Basic net income per common share $ 0.07 $ 0.32 $ 0.08 $ 0.70 Diluted net income per common share $ 0.07 $ 0.31 $ 0.08 $ 0.68

Note B - Inventories, Net (Tabl

Note B - Inventories, Net (Tables)	6 Months Ended
	Dec. 31, 2019
Notes Tables
Schedule of Inventory, Current [Table Text Block]	Dec ember 3 1 , 201 9 June 30, 201 9 Raw materials $ 14,228 $ 18,322 Work in progress 2,696 3,785 Finished goods 6,255 5,002 Reserve (529 ) (1,106 ) $ 22,650 $ 26,003

Note C - Property and Equipme_2

Note C - Property and Equipment (Tables)	6 Months Ended
	Dec. 31, 2019
Notes Tables
Property, Plant and Equipment [Table Text Block]	Depreciable Life In Years Dec ember 3 1 , 2019 June 30, 201 9 Land NA $ 1,200 $ 1,200 Building and building improvements 7 – 39 3,743 3,729 Machinery and equipment 3 – 12 31,130 30,216 Office equipment and furniture 3 – 5 5,284 5,190 Vehicles 3 255 314 Leasehold improvements 1 – 15 17,509 17,468 Total property and equipment 59,121 58,117 Less: accumulated depreciation and amortization (38,508 ) (37,032 ) Property and equipment, net $ 20,613 $ 21,085

Note D - Other Comprehensive _2

Note D - Other Comprehensive (Loss) Income (Tables)	6 Months Ended
	Dec. 31, 2019
Notes Tables
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	Three Months Ended Six Months Ended December 31, 2019 December 31, 201 9 Unrealized Unrealized Defined Gains Defined Gains Benefit (Losses) on Benefit (Losses) on Pension Cash Flow Pension Cash Flow Plan Hedges Total Plan Hedges Total Beginning Balance $ (565 ) $ 1,116 $ 551 $ (491 ) $ 783 $ 292 ASU 2018-02 Adjustment - - - (74 ) (54 ) (128 ) OCI/OCL before reclassifications - (369 ) (369 ) - 932 932 Amounts reclassified from OCI - (808 ) (808 ) - (1,612 ) (1,612 ) Tax effect of OCI activity - 274 274 - 164 164 Net current period OCI/OCL - (903 ) (903 ) (74 ) (570 ) (644 ) Ending Balance $ (565 ) $ 213 $ (352 ) $ (565 ) $ 213 $ (352 ) Three Months Ended Six Months Ended December 31, 2018 December 31, 2018 Unrealized Unrealized Defined Gains Defined Gains Benefit (Losses) on Benefit (Losses) on Pension Cash Flow Pension Cash Flow Plan Hedges Total Plan Hedges Total Beginning Balance $ (387 ) $ 192 $ (195 ) $ (387 ) $ (191 ) $ (578 ) OCI/OCL before reclassifications - 1,784 1,784 - 2,729 2,729 Amounts reclassified from OCI - (674 ) (674 ) - (1,120 ) (1,120 ) Tax effect of OCI activity - (258 ) (258 ) - (374 ) (374 ) Net current period OCI/OCL - 852 852 - 1,235 1,235 Ending Balance $ (387 ) $ 1,044 $ 657 $ (387 ) $ 1,044 $ 657

Note E - Leases (Tables)

Note E - Leases (Tables)	6 Months Ended
	Dec. 31, 2019
Notes Tables
Schedule of Prospective Adoption of New Accounting Pronouncements [Table Text Block]	As Reported June 30, 2019 Adoption of ASC 842 Increase (Decrease) Balance of July 1, 2019 Operating lease right-of-use assets $ — $ 20,774 $ 20,774 Total assets 93,490 20,774 114,264 Deferred rent 543 (543 ) — Long-term liability – Operating leases — 20,897 20,897 Retained earnings 57,380 420 57,800 Total liabilities and equity 93,490 20,774 114,264

Note G - Economic Dependency (T

Note G - Economic Dependency (Tables)	6 Months Ended
	Dec. 31, 2019
Supplier Concentration Risk [Member]
Notes Tables
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	Three Months Ended December 31, Six Months Ended December 31, 2019 2018 2019 2018 Supplier 1 $ 1,734 (a) $ 3,227 4,472 Supplier 2 (a) 1,866 (a) (a) $ 1,734 1,866 $ 3,227 4,472
Customer Concentration Risk [Member]
Notes Tables
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	Three Months Ended December 31, Six Months Ended December 31, 2019 2018 2019 2018 Customer 1 $ 12,422 $ 17,750 $ 26,776 $ 38,827 Customer 2 5,539 6,196 9,509 9,926 Customer 3 (a) 3,890 (a) (a) $ 17,961 $ 27,836 $ 36,285 $ 48,753

Note H - Segment Information (T

Note H - Segment Information (Tables)	6 Months Ended
	Dec. 31, 2019
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Three Months Ended December 31, Six Months Ended December 31, 2019 2018 2019 2018 Net Sales Private label contract manufacturing $ 24,831 $ 31,660 $ 50,841 $ 62,747 Patent and trademark licensing 4,272 4,383 7,457 9,828 Total Net Sales $ 29,103 $ 36,043 $ 58,298 $ 72,575 Three Months Ended December 31, Six Months Ended December 31, 2019 2018 2019 2018 Income from Operations Private label contract manufacturing $ 1,697 $ 2,853 $ 3,312 $ 5,999 Patent and trademark licensing 842 1,475 1,054 3,276 Income from operations of reportable segments 2,539 4,328 4,366 9,275 Corporate expenses not allocated to segments (1,841 ) (2,121 ) (3,723 ) (4,344 ) Total Income from Operations $ 698 $ 2,207 $ 643 $ 4,931
Reconciliation of Assets from Segment to Consolidated [Table Text Block]	Dec ember 31, 2019 June 30, 201 9 Total Assets Private-label contract manufacturing $ 89,666 $ 74,431 Patent and trademark licensing 19,855 19,059 $ 109,521 $ 93,490
Revenue from External Customers by Geographic Areas [Table Text Block]	Three Months Ended December 31, Six Months Ended December 31, 2019 2018 2019 2018 United States $ 17,591 $ 18,549 $ 35,776 $ 36,195 Markets outside of the United States 11,512 17,494 22,522 36,380 Total $ 29,103 $ 36,043 $ 58,298 $ 72,575
Long-lived Assets by Geographic Areas [Table Text Block]	December 31, 2019 June 30, 2019 United States $ 22,303 $ 10,977 Europe 17,833 10,108 Total Long-Lived Assets $ 40,136 $ 21,085
Assets by Geographic Areas [Table Text Block]	Dec ember 3 1 , 2019 June 30, 2019 United States $ 61,620 $ 54,785 Europe 47,901 38,705 Total Assets $ 109,521 $ 93,490
Capital Expenditures by Geographic Areas [Table Text Block]	Six Months Ended Dec ember 3 1 , 2019 Dec ember 3 1 , 2018 United States $ 578 $ 708 Europe 1,055 1,954 Total Capital Expenditures $ 1,633 $ 2,662

Note A - Basis of Presentatio_3

Note A - Basis of Presentation and Summary of Significant Accounting Policies (Details Textual) - USD ($)	Mar. 31, 2019	Sep. 30, 2017	Aug. 07, 2017	Dec. 31, 2019	Dec. 31, 2018	Dec. 28, 2018	Dec. 31, 2019	Dec. 31, 2018	Jun. 30, 2019
Sales Discounts, Noncash								$ 490,000
Sales, Royalty and Licensing Revenue				$ 4,300,000	$ 4,400,000		7,500,000	9,800,000
Royalty Expense				192,000	178,000		359,000	441,000
Investment Income, Interest				$ 50,000	$ 529,000		$ 129,000	$ 1,084,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross				0	0		0	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period				0	0		0	5,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period				0	0		0	0
Share-based Payment Arrangement, Expense				$ 459,000	$ 400,000		$ 892,000	$ 809,000
Foreign Currency Contract, Asset, Fair Value Disclosure				1,600,000			1,600,000		$ 2,300,000
Fair Value, Inputs, Level 1 [Member]
Fair Value, Net Asset (Liability), Total				0			0		0
Fair Value, Inputs, Level 3 [Member]
Fair Value, Net Asset (Liability), Total				0			0		$ 0
Juice Plus + [Member]
Agreement, Term			5 years
Sales Discounts, Cash				395,000			790,000
Kaged Muscle LLC [Member] | Notes Receivable [Member]
Notes, Loans and Financing Receivable, Term		1 year
Financing Receivable, after Allowance for Credit Loss, Current, Total		$ 1,500,000
Notes, Loans and Financing Receivable, Extension Fee						$ 25,000
Notes, Loans and Financing Receivable, Interest Rate, Stated Percentage		15.00%
Investment Income, Interest				$ 0	$ 46,000		$ 0	$ 104,000
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period				5,000	0		5,000	15,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period				0	5,000		15,000	5,000
Restricted Stock [Member] | Juice Plus, Amended and Restated Exclusive Manufacturing Agreement [Member]
Treasury Stock, Shares, Acquired	400,000
Restricted Stock [Member] | Juice Plus + [Member]
Stock Issuance Agreement, Shares Agreed to Grant			500,000
Sales Discounts, Noncash					$ 245,000			$ 490,000

Note A - Basis of Presentatio_4

Note A - Basis of Presentation and Summary of Significant Accounting Policies - Calculation of Basic and Diluted Net Income Per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Numerator
Net income	$ 476	$ 2,181	$ 572	$ 4,740
Denominator
Basic weighted average common shares outstanding (in shares)	6,795,269	6,807,979	6,818,249	6,786,470
Dilutive effect of stock options and restricted stock (in shares)	91,000	191,000	117,000	196,000
Diluted weighted average common shares outstanding (in shares)	6,885,934	6,999,223	6,935,580	6,982,083
Basic net income per common share (in dollars per share)	$ 0.07	$ 0.32	$ 0.08	$ 0.70
Diluted net income per common share (in dollars per share)	$ 0.07	$ 0.31	$ 0.08	$ 0.68

Note B - Inventories, Net (Deta

Note B - Inventories, Net (Details Textual) - USD ($)	Dec. 31, 2019	Jun. 30, 2019
Inventory Valuation Reserves, Ending Balance	$ 529,000	$ 1,106,000
SR CarnoSyn Powder [Member]
Inventory Valuation Reserves, Ending Balance	$ 39,000	$ 686,000

Note B - Inventories, Net - Sum

Note B - Inventories, Net - Summary of Inventories (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Jun. 30, 2019
Raw materials	$ 14,228	$ 18,322
Work in progress	2,696	3,785
Finished goods	6,255	5,002
Reserve	(529)	(1,106)
Inventories, net	$ 22,650	$ 26,003

Note C - Property and Equipme_3

Note C - Property and Equipment - Summary of Property and Equipment (Details) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2019	Jun. 30, 2019
Property and equipment, gross	$ 59,121	$ 58,117
Less: accumulated depreciation and amortization	(38,508)	(37,032)
Property and equipment, net	20,613	21,085
Land [Member]
Property and equipment, gross	1,200	1,200
Building and Building Improvements [Member]
Property and equipment, gross	$ 3,743	3,729
Building and Building Improvements [Member] | Minimum [Member]
Depreciable Life In Years (Year)	7 years
Building and Building Improvements [Member] | Maximum [Member]
Depreciable Life In Years (Year)	39 years
Machinery and Equipment [Member]
Property and equipment, gross	$ 31,130	30,216
Machinery and Equipment [Member] | Minimum [Member]
Depreciable Life In Years (Year)	3 years
Machinery and Equipment [Member] | Maximum [Member]
Depreciable Life In Years (Year)	12 years
Office Equipment [Member]
Property and equipment, gross	$ 5,284	5,190
Office Equipment [Member] | Minimum [Member]
Depreciable Life In Years (Year)	3 years
Office Equipment [Member] | Maximum [Member]
Depreciable Life In Years (Year)	5 years
Vehicles [Member]
Property and equipment, gross	$ 255	314
Depreciable Life In Years (Year)	3 years
Leasehold Improvements [Member]
Property and equipment, gross	$ 17,509	$ 17,468
Leasehold Improvements [Member] | Minimum [Member]
Depreciable Life In Years (Year)	1 year
Leasehold Improvements [Member] | Maximum [Member]
Depreciable Life In Years (Year)	15 years

Note D - Other Comprehensive _3

Note D - Other Comprehensive (Loss) Income (Details Textual)	Jul. 01, 2019USD ($)
Accounting Standards Update 2016-02 [Member]
Tax Cuts and Jobs Act, Reclassification from AOCI to Retained Earnings, Tax Effect	$ 128,000

Note D - Other Comprehensive _4

Note D - Other Comprehensive (Loss) Income - Other Comprehensive (Loss) Income (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Balance	$ 77,405	$ 71,876	$ 76,084	$ 68,248
Balance	76,120	75,130	76,120	75,130
Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]
Balance	(565)	(387)	(491)	(387)
ASU 2018-02 Adjustment			(74)
OCI/OCL before reclassifications
Amounts reclassified from OCI
Tax effect of OCI activity
Net current period OCI/OCL			(74)
Balance	(565)	(387)	(565)	(387)
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]
Balance	1,116	192	783	(191)
ASU 2018-02 Adjustment			(54)
OCI/OCL before reclassifications	(369)	1,784	932	2,729
Amounts reclassified from OCI	(808)	(674)	(1,612)	(1,120)
Tax effect of OCI activity	274	(258)	164	(374)
Net current period OCI/OCL	(903)	852	(570)	1,235
Balance	213	1,044	213	1,044
AOCI Attributable to Parent [Member]
Balance	551	(195)	292	(578)
ASU 2018-02 Adjustment			(128)
OCI/OCL before reclassifications	(369)	1,784	932	2,729
Amounts reclassified from OCI	(808)	(674)	(1,612)	(1,120)
Tax effect of OCI activity	274	(258)	164	(374)
Net current period OCI/OCL	(903)	852	(644)	1,235
Balance	$ (352)	$ 657	$ (352)	$ 657

Note E - Leases (Details Textua

Note E - Leases (Details Textual) - USD ($) $ in Thousands	Dec. 31, 2019	Jul. 01, 2019	Jun. 30, 2019
Operating Lease, Right-of-Use Asset	$ 19,523	$ 20,774
Accounting Standards Update 2016-02 [Member]
Operating Lease, Right-of-Use Asset		20,774
Operating Lease, Liability, Total		$ 20,900

Note E - Leases - Impact of Ado

Note E - Leases - Impact of Adoption of Adoption ASC 842 (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Jul. 01, 2019	Jun. 30, 2019
Operating lease right-of-use assets	$ 19,523	$ 20,774
Total assets	109,521	114,264	93,490
Deferred rent			543
Long-term liability – Operating leases	19,742	20,897
Retained earnings	58,500	57,800	57,380
Total liabilities and equity	$ 109,521	114,264	$ 93,490
Accounting Standards Update 2016-02 [Member]
Operating lease right-of-use assets		20,774
Total assets		20,774
Deferred rent		(543)
Long-term liability – Operating leases		20,897
Retained earnings		420
Total liabilities and equity		$ 20,774

Note F - Debt (Details Textual)

Note F - Debt (Details Textual) - USD ($)	Jul. 01, 2019	Dec. 31, 2019
Proceeds from Long-term Lines of Credit		$ 0
Line of Credit Facility, Remaining Borrowing Capacity		$ 10,000,000
Wells Fargo Bank, N.A. [Member] | Credit Agreement [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 10,000,000
Long-term Debt, Percentage Bearing Fluctuating Interest, Threshold Amount	100,000
Minimum Prepayment Amount Under Line of Credit	$ 100,000
Wells Fargo Bank, N.A. [Member] | Credit Agreement [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument, Basis Spread on Variable Rate	1.25%
Debt Instrument Basis Spread on Elected Fixed Rate Borrowing	1.25%
Wells Fargo Bank, N.A. [Member] | Credit Agreement [Member] | Maximum [Member]
Ratio of Indebtedness to Net Capital	1.25
Ratio of Total Current Assets to Total Current Liabilities	1.75

Note G - Economic Dependency (D

Note G - Economic Dependency (Details Textual) - Product Concentration Risk [Member] - Accounts Receivable [Member]	3 Months Ended	12 Months Ended
	Dec. 31, 2019	Jun. 30, 2019
Number of Major Customers	3
Beta-alanine Raw Material [Member]
Concentration Risk, Percentage	16.10%	8.00%
Three Customers [Member]
Concentration Risk, Percentage	77.10%	76.80%

Note G - Economic Dependency -

Note G - Economic Dependency - Substantial Net Sales to Certain Customers (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Dec. 31, 2019		Dec. 31, 2018	Dec. 31, 2019		Dec. 31, 2018
Net sales	$ 29,103		$ 36,043	$ 58,298		$ 72,575
Customer Concentration Risk [Member] | Revenue Benchmark [Member]
Net sales	17,961		27,836	36,285		48,753
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer 1 [Member]
Net sales	12,422		17,750	26,776		38,827
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer 2 [Member]
Net sales	5,539		6,196	9,509		9,926
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer 3 [Member]
Net sales		[1]	$ 3,890		[1]		[1]
[1]	Sales were less than 10% of the respective period's total net sales.

Note G - Economic Dependency _2

Note G - Economic Dependency - Substantial Net Purchase From Certain Suppliers (Details) - Supplier Concentration Risk [Member] - Raw Material Purchases [Member] - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Dec. 31, 2019	Dec. 31, 2018		Dec. 31, 2019		Dec. 31, 2018
Raw Material Purchases by Supplier	$ 1,734	$ 1,866		$ 3,227		$ 4,472
Supplier 1 [Member]
Raw Material Purchases by Supplier	1,734		[1]	3,227		4,472
Supplier 2 [Member]
Raw Material Purchases by Supplier		$ 1,866			[1]		[1]
[1]	Purchases were less than 10% of the respective period's total raw material purchases.

Note H - Segment Information (D

Note H - Segment Information (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Number of Reportable Segments	2
Revenue from Contract with Customer, Including Assessed Tax	$ 29,103	$ 36,043	$ 58,298	$ 72,575
Non-US [Member]
Revenue from Contract with Customer, Including Assessed Tax	11,512	17,494	22,522	36,380
UNITED STATES
Revenue from Contract with Customer, Including Assessed Tax	$ 17,591	$ 18,549	$ 35,776	$ 36,195
Products Manufactured by NAIE [Member] | Non-US [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]
Concentration Risk, Percentage	91.00%	90.00%	90.00%	80.00%
Products Manufactured by NAIE [Member] | UNITED STATES
Revenue from Contract with Customer, Including Assessed Tax	$ 0	$ 0	$ 0	$ 0

Note H - Segment Information -

Note H - Segment Information - Operating Results by Business Segment (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Net sales	$ 29,103	$ 36,043	$ 58,298	$ 72,575
Income from operations	698	2,207	643	4,931
Operating Segments [Member]
Income from operations	2,539	4,328	4,366	9,275
Corporate, Non-Segment [Member]
Income from operations	(1,841)	(2,121)	(3,723)	(4,344)
Private Label Contract Manufacturing [Member]
Net sales	24,831	31,660	50,841	62,747
Private Label Contract Manufacturing [Member] | Operating Segments [Member]
Income from operations	1,697	2,853	3,312	5,999
Patent and Trademark Licensing [Member]
Net sales	4,272	4,383	7,457	9,828
Patent and Trademark Licensing [Member] | Operating Segments [Member]
Income from operations	$ 842	$ 1,475	$ 1,054	$ 3,276

Note H - Segment Information _2

Note H - Segment Information - Assets by Business Segment (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Jul. 01, 2019	Jun. 30, 2019
Total assets	$ 109,521	$ 114,264	$ 93,490
Private Label Contract Manufacturing [Member]
Total assets	89,666		74,431
Patent and Trademark Licensing [Member]
Total assets	$ 19,855		$ 19,059

Note H - Segment Information _3

Note H - Segment Information - Net Sales by Geographic Region (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Net sales	$ 29,103	$ 36,043	$ 58,298	$ 72,575
UNITED STATES
Net sales	17,591	18,549	35,776	36,195
Non-US [Member]
Net sales	$ 11,512	$ 17,494	$ 22,522	$ 36,380

Note H - Segment Information _4

Note H - Segment Information - Long-lived Assets by Geographical Region (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Jun. 30, 2019
Long-Lived Assets	$ 40,136	$ 21,085
UNITED STATES
Long-Lived Assets	22,303	10,977
Europe [Member]
Long-Lived Assets	$ 17,833	$ 10,108

Note H - Segment Information _5

Note H - Segment Information - Total Assets by Geographical Region (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Jul. 01, 2019	Jun. 30, 2019
Total Assets	$ 109,521	$ 114,264	$ 93,490
UNITED STATES
Total Assets	61,620		54,785
Europe [Member]
Total Assets	$ 47,901		$ 38,705

Note H - Segment Information _6

Note H - Segment Information - Capital Expenditures by Geographical Region (Details) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Capital Expenditures	$ 1,633	$ 2,662
UNITED STATES
Capital Expenditures	578	708
Europe [Member]
Capital Expenditures	$ 1,055	$ 1,954

Note I - Income Taxes (Details

Note I - Income Taxes (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Effective Income Tax Rate Reconciliation, Percent, Total	17.00%	20.70%	17.80%	20.60%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent			21.00%
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$ 0		$ 0
Domestic Tax Authority [Member]
Open Tax Year			2016 2017 2018 2019
State and Local Jurisdiction [Member]
Open Tax Year			2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Foreign Tax Authority [Member] | Swiss Federal Tax Administration (FTA) [Member]
Open Tax Year			2018 2019

Note J - Treasury Stock (Detail

Note J - Treasury Stock (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Jan. 08, 2020
Treasury Stock, Value, Acquired, Cost Method	$ 1,317,000	$ 424,000	$ 1,332,000	$ 430,000
Stock Repurchase Plan [Member]
Stock Repurchase Program, Authorized Amount	$ 7,000,000		$ 7,000,000
Treasury Stock, Shares, Acquired	150,307	36,949	151,338	36,949
Treasury Stock Acquired, Average Cost Per Share	$ 8.33		$ 8.33
Treasury Stock, Value, Acquired, Cost Method	$ 1,300,000	$ 358,000	$ 1,300,000	$ 358,000
Stock Repurchase Plan [Member] | Subsequent Event [Member]
Stock Repurchase Program, Authorized Amount					$ 9,000,000
Stock Repurchase Program, Additional Amount Authorized					$ 2,000,000
Stock Repurchase Plan In Connection With Restricted Stock [Member]
Treasury Stock, Shares, Acquired	7,644	6,864	8,330	7,538
Treasury Stock Acquired, Average Cost Per Share	$ 8.67	$ 9.66	$ 8.74	$ 9.66
Treasury Stock, Value, Acquired, Cost Method	$ 66,000	$ 66,000	$ 73,000	$ 72,000

Note K - Derivatives and Hedg_2

Note K - Derivatives and Hedging (Details Textual) € in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)	Dec. 31, 2019EUR (€)	Jun. 30, 2019USD ($)
Unrealized Gain on Foreign Currency Derivatives, before Tax			$ 276,000
Cash Flow Hedge Derivative Instrument Assets at Fair Value	$ 1,600,000		1,600,000
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax	(369,000)	$ 1,300,000	932,000	$ 1,800,000
Nonoperating Income (Expense) [Member]
Gain (Loss) on Derivative Instruments, Net, Pretax, Total	261,000	464,000	498,000	951,000
Prepaid Expenses and Other Current Assets [Member]
Cash Flow Hedge Derivative Instrument Assets at Fair Value						$ 2,000,000
Other Noncurrent Assets [Member]
Cash Flow Hedge Derivative Instrument Assets at Fair Value						$ 312,000
Reclassification out of Accumulated Other Comprehensive Income [Member]
Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months	305,000		305,000
Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net, Total	$ 808,000	$ 211,000	1,600,000	$ 169,000
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Other Income, Effective Portion, Net			$ 54,000
Foreign Exchange Contract [Member]
Discontinuation of Cash Flow Hedge	0	0	0	0
Foreign Exchange Contract [Member] | Cash Flow Hedging [Member]
Derivative, Notional Amount	$ 40,500,000		$ 40,500,000		€ 34.2